Last reviewed · How we verify
Vero Cell-derived Influenza Vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Vero Cell-derived Influenza Vaccine (Vero Cell-derived Influenza Vaccine) — Alachua Government Services, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vero Cell-derived Influenza Vaccine TARGET | Vero Cell-derived Influenza Vaccine | Alachua Government Services, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vero Cell-derived Influenza Vaccine CI watch — RSS
- Vero Cell-derived Influenza Vaccine CI watch — Atom
- Vero Cell-derived Influenza Vaccine CI watch — JSON
- Vero Cell-derived Influenza Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Vero Cell-derived Influenza Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/vero-cell-derived-influenza-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab